Form 8-K - Current report:
SEC Accession No. 0001213900-24-076728
Filing Date
2024-09-09
Accepted
2024-09-09 09:00:09
Documents
15
Period of Report
2024-09-03
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0213202-8k_allarity.htm   iXBRL 8-K 52249
2 SIXTH CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF ALLARITY THERA ea021320201ex3-1_allarity.htm EX-3.1 9323
3 SEVENTH CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF ALLARITY THE ea021320201ex3-2_allarity.htm EX-3.2 10788
  Complete submission text file 0001213900-24-076728.txt   260498

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE allr-20240903.xsd EX-101.SCH 3015
5 XBRL LABEL FILE allr-20240903_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE allr-20240903_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0213202-8k_allarity_htm.xml XML 3915
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 241286015
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)